| An Update on Radial Artery Access and Best Practices for Transradial Coronary Angiography and Intervention in Acute Coronary Syndrome A Scientific Statement From the American Heart Association |
68 |
| High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions: The Randomized PREPARE-CALC Trial |
37 |
| Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses The Disrupt CAD II Study |
36 |
| Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries Long-Term Results of the IN.PACT SFA Randomized Trial |
34 |
| Concomitant Intra-Aortic Balloon Pump Use in Cardiogenic Shock Requiring Veno-Arterial Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis |
25 |
| Bicuspid Aortic Valve Anatomy and Relationship With Devices: The BAVARD Multicenter Registry A European Picture of Contemporary Multidetector Computed Tomography Sizing for Bicuspid Valves |
21 |
| Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy |
20 |
| Early and Late Leaflet Thrombosis After Transcatheter Aortic Valve Replacement A Multicenter Initiative From the OCEAN-TAVI Registry |
19 |
| Temporal Trends in Chronic Total Occlusion Interventions in Europe 17626 Procedures From the European Registry of Chronic Total Occlusion |
18 |
| Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions Five-Year Outcomes From the IN.PACT SFA Randomized Trial |
17 |
| Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention |
17 |
| Catheter-Based Measurements of Absolute Coronary Blood Flow and Microvascular Resistance Feasibility, Safety, and Reproducibility in Humans |
16 |
| Clopidogrel Pharmacogenetics State-of-the-Art Review and the TAILOR-PCI Study |
16 |
| Interventional Treatment of Severe Tricuspid Regurgitation Early Clinical Experience in a Multicenter, Observational, First-in-Man Study |
15 |
| Patient-Specific Computer Simulation to Elucidate the Role of Contact Pressure in the Development of New Conduction Abnormalities After Catheter-Based Implantation of a Self-Expanding Aortic Valve |
15 |
| Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device The SAFE MANTA Study |
15 |
| North American Expert Review of Rotational Atherectomy |
15 |
| Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease |
14 |
| Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry |
14 |
| Transcarotid Compared With Other Alternative Access Routes for Transcatheter Aortic Valve Replacement |
13 |
| Length of Stay and Discharge Disposition After Transcatheter Versus Surgical Aortic Valve Replacement in the United States |
13 |
| Safety and Efficacy of Polymer-Free Drug-Eluting Stents Amphilimus-Eluting Cre8 Versus Biolimus-Eluting BioFreedom Stents |
12 |
| Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population Final Results From the OBSERVANT Study |
12 |
| Coronary Embolism Among ST-Segment-Elevation Myocardial Infarction Patients: Mechanisms and Management |
12 |
| Intentional Fracture of Bioprosthetic Valve Frames in Patients Undergoing Valve-in-Valve Transcatheter Pulmonary Valve Replacement |
11 |
| Restenosis of Drug-Eluting Stents A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review |
11 |
| Procedural Success and Outcomes With Increasing Use of Enabling Strategies for Chronic Total Occlusion Intervention An Analysis of 28050 Cases From the British Cardiovascular Intervention Society Database |
11 |
| Successful Feasibility Human Trial of a New Self-Expandable Percutaneous Pulmonary Valve (Pulsta Valve) Implantation Using Knitted Nitinol Wire Backbone and Trileaflet alpha-Gal-Free Porcine Pericardial Valve in the Native Right Ventricular Outflow Tract |
11 |
| Predicting the Physiological Effect of Revascularization in Serially Diseased Coronary Arteries Clinical Validation of a Novel CT Coronary Angiography-Based Technique |
11 |
| Early Natural History of Spontaneous Coronary Artery Dissection |
10 |
| Surgical Atrioventricular Valve Replacement With Melody Valve in Infants and Children A Multicenter Study |
10 |
| Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes |
10 |
| Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition A Multicenter French Study |
10 |
| Endovascular Thrombectomy in Acute Ischemic Stroke |
10 |
| Retroperitoneal Hemorrhage After Percutaneous Coronary Intervention Incidence, Determinants, and Outcomes as Recorded by the British Cardiovascular Intervention Society |
9 |
| Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention A Subgroup Analysis of the BIOSCIENCE Randomized Trial |
9 |
| Performance of PRECISE-DAPT Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy |
9 |
| Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis Insights From the REAL-ST Registry |
9 |
| Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions Results From the Coronary Bifurcation Stenting Registry II |
9 |
| Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement |
9 |
| Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice Results From the Bern Percutaneous Coronary Intervention Registry |
8 |
| Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population Analysis From the ADAPT-DES Registry |
8 |
| Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention Technique Analysis From the EXCEL Trial |
8 |
| Antithrombotic Therapy After Transcatheter Aortic Valve Replacement |
8 |
| Impact of Coronary Artery Revascularization Completeness on Outcomes of Patients With Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement A Meta-Analysis of Studies Using the Residual SYNTAX Score (Synergy Between PCI With Taxus and Cardiac Surgery) |
8 |
| Routine Fractional Flow Reserve Measurement After Percutaneous Coronary Intervention The FFR-SEARCH Study |
8 |
| Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease Insights From the SYNTAX III REVOLUTION Trial |
8 |
| Ischemia and No Obstructive Coronary Artery Disease Prevalence and Correlates of Coronary Vasomotion Disorders |
8 |
| Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions |
8 |
| Validation of Resting Diastolic Pressure Ratio Calculated by a Novel Algorithm and Its Correlation With Distal Coronary Artery Pressure to Aortic Pressure, Instantaneous Wave-Free Ratio, and Fractional Flow Reserve The dPR Study |
7 |
